Lancet曰く、メタボはたいした指標じゃないよ、と

　⇒Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies : The Lancet

Metabolic syndrome and its components are associated with type 2 diabetes but have weak or no association with vascular risk in elderly populations, suggesting that attempts to define criteria that simultaneously predict risk for both cardiovascular disease and diabetes are unhelpful. Clinical focus should remain on establishing optimum risk algorithms for each disease.